Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women

Archives of Neurology

Volumn 54, Issue 9, 1997, Pages 1110-1114

  Yaffe, Kristine ^a,b   Cauley, Jane ^a   Sands, Laura ^a   Browner, Warren ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AGING; ALLELE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HUMAN; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MENTAL HEALTH; NEUROPSYCHOLOGICAL TEST; PHENOTYPE; PRIORITY JOURNAL;

EID: 0030870127     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.1997.00550210044011     Document Type: Article

References (37)

1. Kokmen E, Beard CM, O'Brien PC, Kurland LT. Epidemiology of dementia in Rochester, Minnesota. Mayo Clin Proc. 1996;71:275-282.
2. Flicker C, Ferris SH, Reisberg B. Mild cognitive impairment in the elderly: predictors of dementia. Neurology. 1991 ;41:1006-1009.
3. Deeg DJ, Hofman A, van Zanneveld ZR. The association between change in cognitive function and longevity in Dutch elderly. Am J Epidemiol. 1990:132:973982.
4. Ganguli M, Seaberg E, Belle S, Fischer L, Kuller LH. Cognitive impairment and the use of health services in an elderly rural population: the MoVlES project Monongahela Valley Independent Elders Survey. J Am GeriatrSoc. 1993:41:10651070.
5. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993:261:921-923.
6. Mayeux R, Stern Y, Oilman R, et al. The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease. Ann Neurol. 1993:34:752-754.
7. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993;43:1467-1472.
8. Utermann G, Langenbeck U, Beisiegel U, Weber W. Genetics of the apolipoprotein E system in man. Am J Hum Genet. 1980:32:339-347.
9. Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet. 1994;7:180-184.
10. Gomez IT, West HL, Rebeck GW, et al. Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease. Ann Neurol. 1996:39:62-70.
11. Aronson MK, Ooi WL, Morgenstern H, et al. Women, myocardial infarction, and dementia in the very old. Neurology. 1990:40:1102-1106.
12. Payami H, Montée KR, Kaye JA, et al. Alzheimer's disease, apolipoprotein and gender. JAMA. 1994:271:1316-1317.
13. Schaefer EJ, Lamon FS, Johnson S, et al. Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels: results from the Framingham Offspring Study. Arterioscler Thromb. 1994; 14:1105-1113.
14. Payami H, Montée K, Grimslid H, Shattuc S, Kaye J. Increased risk of familial late-onset Alzheimer's disease in women. Neurology. 1996:46:126-129.
15. Cummings SR, Black DM, Nevitt MC, et al. Appendicular bone density and age predict hip fracture in women: the Study of Osteoporotic Fractures Research Group. JAMA. 1990:263:665-668.
16. Yesavage JA. Geriatric Depression Scale. PsychopharmacolBull. 1988:24:709711.
17. Bailey IL, Lovie JE. New design principles for visual acuity letter charts. Am J Optom Physio! Opt. 1976;53:740-745.
18. Kamboh Ml, Ferrell RE, Kottke B. Genetic studies of human apolipoproteins, V: a novel rapid procedure to screen apolipoprotein E polymorphism. J Llpid Res. 1988:29:1535-1543.
19. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry. 1987;48:314-318.
20. Magaziner J, Bassett SS, Hebel JR. Predicting performance on'the Mini-Mental State Examination: use of age- and education-specific equations. JAm Geriatr Soa 1987:35:996-1000.
21. Reitàn R. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills. 1958:8:271-276.
22. Wechsler D. Wechsler Adult Intelligence Scale-Revised. New York, NY: Psychological Corp; 1988.
23. Feskens EJ, Havekes LM, Kalmijn S, et al. Apolipoprotein e4 allele and cognitive decline in elderly men. BMJ. 1994;309:1202-1206.
24. Hyman B, Gomex-lsla T, Briggs M, et al. Apolipoprotein E and cognitive change in an elderly population. Ann Neurol. 1996:40:55-66.
25. Soininen H, Partanen K, Pitkanen A, et al. Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E epsilon 4 allele. Neurology. 1995:45:391-392.
26. Small GW, Mazziotta JC, Collins MT, et al. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA. 1995:273:942-947.
27. Reiman E, Casein R, Yun L, et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the t4 allele for apolipoprotein E. NEnglJMed. 1996; 334:752-758.
28. Reed T, Carmelli D, Swan GE, et al. Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E epsilon 4 allele. Arch Neurol. 1994; 51:1189-1192.
29. Helkala EL, Koivisto K, Hanninen T, et al. The association of apolipoprotein Epolymorpnism with memory; a population based study. Neurosci Lett. 1995;191: 141-144.
30. Bondi M, Salmon D, Monsch A, et al. Episodic memory changes are associated with the ApoE-e4 allele in nondemented older adults. Neurology. 1995;45:22032206.
31. Schmechel DE, Saunders AM, Strittmatter WJ, et al. Increased amyloid betapeptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc NatlAcad Se! USA.î 1993;90:96499653.
32. Strittmatter WJ, Saunders AM, Goedert M, et al. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. Proc NatlAcad Sei U S A. 1994;91:11183-11186.
33. Hyman BT, West HL, Rebeck GW, Lai F, Mann DM. Neuropathological changes in Down's syndrome hippocampal formation: effect of age and apolipoprotein E genotype. Arch Neurol. 1995;52:373-378.
34. Mann DM, Brown AM, Prinja D, Jones D, Davies ÇA. A morphological analysis of senile plaques in the brains of non-demented persons of different ages using silver, immunocytochemical and lectin histochemical staining techniques. NeuropatholAppI Neurobiol. 1990;16:17-25.
35. Corder EH, Saunders AM, Strittmatter WJ, et al. Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease. Neurology. 1995:45:1323-1328.
36. Petersen RC, Smith GE, Ivnik RJ, et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA. 1995;273:1274-1278.
37. Tierney MC, Szalai JP, Snow WG, et al. A prospective study of the clinical utility of ApoE genotype in the prediction of outcome in patients with memory impairment. Neurology. 1996;46:149-154.